While assessing BMI is an important first step, treatment decisions always involve thorough discussions with each patient to ensure that recommended therapies align with their unique health needs, goals, and preferences
Please note that Highmark will provide the meeting link via email (to those that have registered in advance) on the morning of the webinar
In this article, we compare 10 GLP-1 agonist medications
On April 30, 2026 , the FDA proposed leaving semaglutide, tirzepatide, and liraglutide off the 503B bulks list entirely, saying there is no clinical need for large-scale compounding
Each recipe provides 25-30 grams of protein
JAMA Surg 151(11):10461055 Schauer PR, Bhatt DL, Kirwan JP et al (2014) Bariatric surgery versus intensive medical therapy for diabetes 3-year outcomes